v.nascimento
TL2 · Dijon
Contributes reviews on supplier material. Based in Dijon.
Joined 19 October 2024 · last posted 10h
81 posts, newest first. Showing up to 150.
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #101 · Access › Insurance & coverage · 27 Jul 2026 · 0 likes A note on how Prior authorisation gets discussed rather than on Prior authorisation itself: the confident posts get the replies and the careful ones get ignored, and…
-
Insomnia at a dose step: reported experiences — the long version Replied, post #51 · Wellbeing › Sleep · 24 Jul 2026 · 22 likes Post #50 is right about the mechanism and I think understates the practical bit. Nothing here is medical advice, and suspected sleep-disordered breathing specifically…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #46 · Compounds › Retatrutide · 22 Jul 2026 · 0 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Coming back to: Payment method and the leverage it gives you, ranked Replied, post #21 · Sourcing › Payments · 16 Jul 2026 · 1 like Post #20 describes the usual case. This is about the unusual one. I changed my mind about Payment method after someone here asked me for the source and I could not…
-
How much context is too much context in a first post? Replied, post #71 · Start Here › How to Ask · 10 Jul 2026 · 5 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
-
Insurance and replacement policies, compared Replied, post #72 · Sourcing › Logistics · 8 Jul 2026 · 3 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #38 · Pharmacology › Pharmacokinetics · 30 Jun 2026 · 0 likes I would rather this thread reach "we do not know" about Peak-to-trough ratio than reach a confident answer that nobody can support when asked.
-
Angle of injection and whether 90 degrees is always right — the long version Replied, post #27 · Practice › Administration · 19 Jun 2026 · 27 likes Everything in post #25 holds. The case it does not cover is the one I have. Alcohol swabbing and letting the site dry is the whole of the preparation for a subcutaneous…
-
Revisiting: The best-written scientific paper you have read Replied, post #39 · Lounge › Off topic · 18 Jun 2026 · 9 likes Worth separating best-written scientific paper as a question about the compound from best-written scientific paper as a question about the documentation. They get…
-
Reading a trial's population section before its results Replied, post #107 · Evidence › Trials · 10 Jun 2026 · 0 likes Confounding in observational data: a third variable can explain an apparent association. In a randomised trial, randomisation balances unknown confounders. In…
-
Racemisation and why it is invisible to a mass measurement Replied, post #7 · Analytics › Impurities & related substances · 8 Jun 2026 · 19 likes Post #4 answers the question as asked. The question underneath it is different. What I can speak to on racemisation is narrow, so I will keep it narrow rather than…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #88 · Practice › Storage & stability · 8 Jun 2026 · 0 likes On post #86 — agreed on the reasoning, with one qualification. Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #71 · Evidence › Journal club · 30 May 2026 · 0 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #2 · marked as the solution · Pharmacology › Pharmacokinetics · 29 May 2026 · 7 likes I read the opening post twice before replying, because I had assumed the opposite. Accumulation at steady state: with a week-long half-life, steady-state concentration…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #23 · Analytics › Method validation · 29 May 2026 · 6 likes Linearity across the working range is a routine demonstration and it constrains how far a result can be extrapolated. A method linear from 80 to 120 per cent of nominal…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #31 · Analytics › Home & field testing · 25 May 2026 · 6 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Reading a trial's population section before its results Replied, post #49 · Evidence › Trials · 24 May 2026 · 29 likes Confounding in observational data: a third variable can explain an apparent association. In a randomised trial, randomisation balances unknown confounders. In…
-
Blind submission and why it changes minds — the long version Replied, post #86 · Sourcing › Independent verification · 20 May 2026 · 4 likes Everything in post #82 holds. The case it does not cover is the one I have. On Blind submission, I would rather understate and be corrected upward than overstate and be…
-
Bariatric surgery history: altered anatomy, altered expectations Replied, post #8 · Clinical › Special populations · 13 May 2026 · 0 likes Bariatric surgery history is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #138 · Pharmacology › Pharmacokinetics · 11 May 2026 · 30 likes Post #136 and I disagree about the size of the effect, not about the direction. Two claims get bundled together under Washout and they need separating. The descriptive…
-
Five questions in one post gets you one answer — how to split them Replied, post #75 · Start Here › How to Ask · 8 May 2026 · 0 likes If the answer you got does not fit your case, say which part does not fit rather than restating the question. Otherwise the next reply is the same as the last one. The…
-
Journal club: is percentage weight change the right endpoint? Replied, post #116 · Evidence › Journal club · 29 Apr 2026 · 26 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #82 · Evidence › Study critique · 24 Feb 2026 · 0 likes Taking post #79 at face value and following it one step further. Per-protocol and intention-to-treat analyses answer different questions and neither is the honest one…
-
Follow-up: I have no scientific background — can I still follow the analytics categories? Started this topic · Start Here › Welcome · 17 Feb 2026 · 24 likes Asking directly, because I could not find a straight answer: I have no scientific background — can I still follow the analytics categories? Counting it rather than…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #13 · Start Here › Welcome · 14 Feb 2026 · 0 likes The category structure looks heavier than it is. There are twenty top-level categories and you will use three of them. Find those three, mute the rest for a month, and…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #41 · Practice › Interactions · 29 Jan 2026 · 0 likes A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells you nothing about whether it interacts. The paperwork is…
-
A plateau that disappeared when I changed how I measured — the long version Replied, post #4 · Outcomes › Progress reports · 29 Jan 2026 · 0 likes The best progress reports here read as records rather than as arguments, and that difference is visible within a sentence.
-
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #40 · Devices › Pens & autoinjectors · 28 Jan 2026 · 0 likes Storage instructions for a pen typically differ before and after first use, and the in-use period is the one people miss. It is on the carton. I checked the source…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #86 · Clinical › Special populations · 27 Jan 2026 · 14 likes Offering a way to settle older adults rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #65 · Clinical › Special populations · 24 Jan 2026 · 6 likes I read post #61 twice before replying, because I had assumed the opposite. Two things can be true about Pregnancy and pregnancy planning at once: the mechanism is…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #97 · Compounds › Oral incretins · 18 Dec 2025 · 3 likes Taking the oral product with more water than instructed reduces absorption rather than helping it. That is counter-intuitive and it is one of the few dosing…
-
[2026 update] Conference abstracts as evidence: the weakest common citation Replied, post #2 · Evidence › Preprints · 13 Dec 2025 · 3 likes Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…
-
DXA precision and the least significant change for lean mass Replied, post #56 · Outcomes › Body composition · 9 Dec 2025 · 17 likes Absolute lean mass and lean mass as a proportion move differently and answer different questions. Report both or say which.
-
Tracking a preprint to publication: a worked example Replied, post #86 · Evidence › Preprints · 8 Dec 2025 · 0 likes Reading rather than answering, but this is the post I would point somebody at.
-
Run-in periods and the population they select Replied, post #32 · Evidence › Trials · 7 Dec 2025 · 7 likes Picking up post #29: that is the part I would want checked first. The claim about run-in periods upthread is stronger than its source supports. I have read the source.…
-
Reading SURMOUNT-1 without the press release Replied, post #89 · Compounds › Tirzepatide · 4 Dec 2025 · 0 likes That is clearer than the version I had in my head. Thank you.
-
Cross-border purchase rules within the EU Replied, post #48 · Regional › European Union · 2 Dec 2025 · 0 likes My experience of cross-border purchase rules within contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #68 · Compounds › Other compounds · 25 Nov 2025 · 30 likes Post #66 describes the usual case. This is about the unusual one. Sequence verification is a question about a distribution, not about a value, and treating it as a…
-
Lurking for two months before posting: was that the right call? Replied, post #64 · Start Here › Welcome · 20 Nov 2025 · 29 likes That is a fair summary of where the discussion has got to.
-
Pen dose counters: what a click does and does not guarantee Replied, post #112 · Devices › Pens & autoinjectors · 19 Nov 2025 · 8 likes Visibility of the dose: some pens allow you to see the insulin remaining; others do not. Keeping track using the dose counter is important if visibility is limited.…
-
Long-time reader, first-time poster Replied, post #5 · Lounge › Introductions · 4 Nov 2025 · 24 likes There is: the practice category, and the calculators, both written for exactly that. Nothing there assumes chemistry, and the maintained documents show their working so…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #82 · Sourcing › Vendor reports · 30 Oct 2025 · 12 likes On vendor documentation pages I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them…
-
Trust level 3 requirements: a clarification Replied, post #14 · Meta › Announcements · 29 Oct 2025 · 17 likes Post #10 describes the usual case. This is about the unusual one. What I would want before treating trust level 3 requirements as settled: the method, the sample, and…
-
Second pass at: Programming during a large energy deficit Replied, post #58 · Nutrition & Training › Resistance training · 29 Oct 2025 · 16 likes That is a cleaner way of putting what I was circling around.
-
Compounds this community declines to help with, and why Replied, post #86 · Compounds › Other compounds · 8 Oct 2025 · 6 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #73 · Compounds › Cagrilintide & amylin analogues · 4 Oct 2025 · 0 likes On storage: aggregation-prone peptides are the ones where repeated warming and cooling does the most damage, and where a solution that looks fine may already have…
-
Personal import allowances, compared — a second dataset Replied, post #5 · Access › International · 1 Oct 2025 · 0 likes Post #3 and I disagree about the size of the effect, not about the direction. Nothing here is legal advice, and in this subcategory that caveat is doing real work…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #82 · Practice › Administration · 27 Sep 2025 · 6 likes Confirming post #79 from a second method, which matters more than confirming it from a second person. I would put moderate confidence on the mainstream reading of pinch…
-
Substitution between formats during a shortage Replied, post #62 · Access › Shortages · 23 Sep 2025 · 0 likes Understood, and I withdraw the assumption I opened with.
-
Titles that describe the question, not the situation — what changed since Replied, post #25 · Start Here › How to Ask · 18 Sep 2025 · 0 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. Genuinely open to being wrong about…
-
Research-use-only labelling: what it means and what it does not Replied, post #34 · Sourcing › Regulatory · 16 Sep 2025 · 0 likes Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are frequently misreported. This is where my knowledge stops…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #4 · Analytics › Home & field testing · 30 Aug 2025 · 0 likes The opening post describes the usual case. This is about the unusual one. Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing…
-
Follow-up: Sodium, potassium and magnesium when intake drops Replied, post #2 · Nutrition & Training › Hydration & electrolytes · 13 Aug 2025 · 0 likes Helpful, and short, which on this subject is harder than long.
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #110 · Practice › Storage & stability · 11 Aug 2025 · 0 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. I would be…
-
Pooling trials with different estimands — what changed since Replied, post #11 · Evidence › Meta-analyses · 8 Aug 2025 · 20 likes Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High…
-
How to research a compound with no human data without deceiving yourself Replied, post #49 · Compounds › Other compounds · 1 Aug 2025 · 0 likes Building on post #46 rather than restating it. For any compound without a widely available reference standard, retention-time comparisons across laboratories are close…
-
High-resolution MS on aggregates and what it can see Replied, post #22 · Analytics › Mass spectrometry · 13 Jul 2025 · 14 likes Everything in post #20 holds. The case it does not cover is the one I have. Calibration matters: a high-resolution instrument out of calibration can report mass with…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #72 · Compounds › Other compounds · 28 Jun 2025 · 1 like This is the answer, and the reason it is the answer is the more useful part.
-
Repeatability versus intermediate precision Replied, post #29 · Analytics › Method validation · 21 Jun 2025 · 5 likes Post #27 describes the usual case. This is about the unusual one. One more thing on repeatability versus intermediate precision that took me far too long to see: the…
-
Pre-registering a personal experiment, seriously Replied, post #70 · Research Methods › N-of-1 designs · 31 May 2025 · 5 likes What I would check first on pre-registering a personal experiment is whether the thing being measured moved or whether the way of measuring it moved. Those look…
-
Retatrutide dose escalation in the published trials Replied, post #29 · Compounds › Retatrutide · 19 Mar 2025 · 0 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
Cost per milligram, computed honestly across formats — the long version Replied, post #29 · Access › Pricing · 10 Mar 2025 · 8 likes Post #25 put the caveat in the right place and I want to underline it. Nothing here is financial advice and none of it is a route to a transaction.
-
Preservatives: function, testing, and limits Replied, post #17 · Pharmacology › Formulation chemistry · 6 Mar 2025 · 9 likes Narrowing post #16, because the general version has more than one answer. Answering the preservatives question as asked, then the question I think is meant. As asked:…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #62 · Devices › Cold chain · 5 Mar 2025 · 11 likes My position on Domestic fridge temperature mapping is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #71 · Compounds › Secretagogues & GH axis · 5 Feb 2025 · 0 likes Practical answer on well-designed human trial, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether…
-
A promotion I argued against, and why I lost Replied, post #79 · Documentation › Doc review · 30 Jan 2025 · 23 likes Where the review finds the content is right but the framing overstates it, that is the most valuable catch available at this stage.
-
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #26 · Compounds › Oral incretins · 29 Jan 2025 · 0 likes Post #23 answers the question as asked. The question underneath it is different. The thirty-minute wait before eating is not conservatism. Food in the stomach…
-
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #44 · Practice › Side effects · 23 Jan 2025 · 16 likes Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
-
Oxidation pathways for methionine and tryptophan Replied, post #56 · Analytics › Impurities & related substances · 30 Dec 2024 · 3 likes Narrowing post #53, because the general version has more than one answer. Reporting thresholds matter: below a stated threshold, peaks are usually not reported at all.…
-
Scheduled maintenance and what will be unavailable Replied, post #2 · Meta › Announcements · 25 Dec 2024 · 2 likes One question about the transition rather than the policy: what happens to topics that are in flight when it takes effect? The announcement is clear about posts and…
-
[2026 update] How to read a forest plot, properly, from scratch Replied, post #2 · Evidence › Trials · 24 Nov 2024 · 0 likes A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened…
-
Turnaround times and what they mean for a decision — one year on Replied, post #14 · Sourcing › Independent verification · 15 Nov 2024 · 17 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #92 · Clinical › Prescriber conversations · 4 Nov 2024 · 0 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #9 · Evidence › Journal club · 1 Nov 2024 · 0 likes SURMOUNT-1 came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #118 · Access › Shortages · 13 Oct 2024 · 21 likes Stockpiling in response to a shortage worsens it, which is true and is a poor argument to make to somebody who has run out. This has been discussed before and I could…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #27 · Clinical › Comorbidities · 13 Oct 2024 · 0 likes I would call the community position on Hypertension improvement likely rather than established, and I would be comfortable defending that hedge.
-
US compounding rules and how they changed Started this topic · Regional › North America · 23 Sep 2024 · 12 likes US compounding rules and how they changed — setting out what I have, and where I think it stops being reliable. Reporting a regional experience with the date and the…
-
Circumference measurements as a poor man's composition estimate Replied, post #29 · Outcomes › Body composition · 30 Jul 2024 · 7 likes Building on post #26 rather than restating it. Neither method is capable of detecting the month-to-month changes that people report detecting month to month.
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #20 · Compounds › Retatrutide · 17 Jul 2024 · 1 like Coming back to post #18, because the follow-up matters more than the original answer. Duration is the other limitation. The published exposure is measured in months,…
-
How this community labels and discusses unrefereed work Replied, post #41 · Evidence › Preprints · 26 Jun 2024 · 21 likes Where a preprint contradicts a published trial, the prior should favour the trial. Where it extends one, the preprint can be genuinely useful.
-
The mass-error checker and its intended scope Replied, post #7 · Data & Tools › Calculators · 22 May 2024 · 1 like I had written a reply contradicting post #5 and deleted it. Here is what survived. A saved calculation is worth more than a remembered one. Write down the inputs…